HK1013996A1 - Quinolone and acridinone derivatives for the treatment of urinary incontinence - Google Patents
Quinolone and acridinone derivatives for the treatment of urinary incontinenceInfo
- Publication number
- HK1013996A1 HK1013996A1 HK98115406A HK98115406A HK1013996A1 HK 1013996 A1 HK1013996 A1 HK 1013996A1 HK 98115406 A HK98115406 A HK 98115406A HK 98115406 A HK98115406 A HK 98115406A HK 1013996 A1 HK1013996 A1 HK 1013996A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- treatment
- urinary incontinence
- quinolone
- acridinone
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
- C07D219/04—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
- C07D219/06—Oxygen atoms
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02E—REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
- Y02E60/00—Enabling technologies; Technologies with a potential or indirect contribution to GHG emissions mitigation
- Y02E60/30—Hydrogen technology
- Y02E60/36—Hydrogen production from non-carbon containing sources, e.g. by water electrolysis
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Quinoline Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9221989A GB9221989D0 (en) | 1992-10-20 | 1992-10-20 | Heterocyclic derivatives |
| GB939308065A GB9308065D0 (en) | 1993-04-20 | 1993-04-20 | Heterocyclic derivatives |
| PCT/GB1993/002125 WO1994008966A1 (en) | 1992-10-20 | 1993-10-14 | Quinolone and acridinone derivatives for the treatment of urinary incontinence |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1013996A1 true HK1013996A1 (en) | 1999-09-17 |
Family
ID=26301823
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK98115406A HK1013996A1 (en) | 1992-10-20 | 1998-12-24 | Quinolone and acridinone derivatives for the treatment of urinary incontinence |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP0665834B1 (fi) |
| JP (1) | JP3315699B2 (fi) |
| KR (1) | KR100296657B1 (fi) |
| AT (1) | ATE201671T1 (fi) |
| AU (1) | AU673696B2 (fi) |
| CA (1) | CA2146763C (fi) |
| DE (1) | DE69330282T2 (fi) |
| DK (1) | DK0665834T3 (fi) |
| ES (1) | ES2160602T3 (fi) |
| FI (1) | FI110940B (fi) |
| GB (2) | GB9318935D0 (fi) |
| GR (1) | GR3036442T3 (fi) |
| HK (1) | HK1013996A1 (fi) |
| HU (2) | HU215386B (fi) |
| IL (1) | IL107287A (fi) |
| NO (1) | NO303222B1 (fi) |
| NZ (1) | NZ256719A (fi) |
| PT (1) | PT665834E (fi) |
| RU (1) | RU2124006C1 (fi) |
| TW (1) | TW261616B (fi) |
| WO (1) | WO1994008966A1 (fi) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9407432D0 (en) * | 1994-04-14 | 1994-06-08 | Zeneca Ltd | Heterocyclic derivative |
| GB9707695D0 (en) * | 1996-08-07 | 1997-06-04 | Hoffmann La Roche | Tricyclic dione derivatives |
| US6593335B1 (en) * | 1997-12-18 | 2003-07-15 | Abbott Laboratories | Potassium channel openers |
| IL135985A0 (en) * | 1997-12-18 | 2001-05-20 | Abbott Lab | Potassium channel openers |
| US6265417B1 (en) | 1997-12-18 | 2001-07-24 | Abbott Laboratories | Potassium channel openers |
| AU1459500A (en) * | 1998-10-28 | 2000-05-15 | Abbott Laboratories | Dihydropyridine compounds and methods of use |
| US6642222B2 (en) * | 1998-10-28 | 2003-11-04 | Abbott Laboratories | Pyrano, piperidino, and thiopyrano compounds and methods of use |
| US6191140B1 (en) | 1998-10-28 | 2001-02-20 | Abbott Laboratories | Pyrano, piperidino, and thiopyrano compounds and methods of use |
| US6518279B2 (en) | 1999-03-04 | 2003-02-11 | Abbott Laboratories | Cyclopentanone dihydropyridine compounds useful as potassium channel openers |
| EP1307429B1 (en) | 2000-08-02 | 2007-11-28 | AstraZeneca AB | Process for asymmetric synthesis of substituted 1,4-dihydropyridines |
| WO2002010103A1 (en) * | 2000-08-02 | 2002-02-07 | Astrazeneca Ab | PROCESS FOR SYNTHESIS OF α,β-UNSATURATED KETONES |
| FR2856687B1 (fr) * | 2003-06-25 | 2005-09-16 | Servier Lab | Nouveaux derives de benzo[a]pyrano[3,2-h]acridin-7-one, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| UA92009C2 (ru) | 2005-05-04 | 2010-09-27 | Н.В. Органон | Производные 4-фенил-5-оксо-1,4,5,6,7,8-гексагидрохинолина для лечения бесплодия |
| UA92007C2 (ru) * | 2005-05-04 | 2010-09-27 | Н.В. Органон | Производные 4-фенил-5-оксо-1,4,5,6,7,8-гексагидрохинолина для лечения бесплодности |
| ES2361674T3 (es) * | 2005-05-04 | 2011-06-21 | N.V. Organon | Derivados de dihidropiridina. |
| UA92008C2 (en) | 2005-05-04 | 2010-09-27 | Н.В. Органон | 4-PHENYL-5-OXO-l,4,5,6,7,8-HEXAHYDROQUINOLINE DERIVATIVES AS MEDICAMENTS FOR THE TREATMENT OF INFERTILITY |
| US8916550B2 (en) | 2005-05-09 | 2014-12-23 | Hydra Biosciences, Inc. | Compounds for modulating TRPV3 function |
| TWI401254B (zh) * | 2005-05-09 | 2013-07-11 | Hydra Biosciences Inc | 用於調節ｔｒｐｖ３功能之化合物 |
| US11976041B1 (en) | 2023-10-23 | 2024-05-07 | King Faisal University | 9-(5-bromo-2-hydroxyphenyl)-10-[3-(dimethylamino)propyl]-3,4,6,7,9,10-hexahydroacridine-1,8(2H,5H)-dione as an antimicrobial compound |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2003148A1 (de) * | 1970-01-24 | 1971-07-29 | Bayer Ag | Neue 1,4-Dihydropyridinderivate |
| DE2018738A1 (en) * | 1970-04-18 | 1971-10-28 | Farbenfabriken Bayer Ag, 5090 Leverkusen | Hydrogenated pyridines, quinolines andacridi |
| GB9220570D0 (en) * | 1991-10-21 | 1992-11-11 | Ici Plc | Therapeutic agent |
| ATE161531T1 (de) * | 1991-10-21 | 1998-01-15 | Zeneca Ltd | Acridine-1,8-dionderivate als therapeutisches mittel |
-
1993
- 1993-09-14 GB GB939318935A patent/GB9318935D0/en active Pending
- 1993-09-28 GB GB939319938A patent/GB9319938D0/en active Pending
- 1993-10-14 AT AT93922605T patent/ATE201671T1/de not_active IP Right Cessation
- 1993-10-14 JP JP50977194A patent/JP3315699B2/ja not_active Expired - Fee Related
- 1993-10-14 EP EP93922605A patent/EP0665834B1/en not_active Expired - Lifetime
- 1993-10-14 NZ NZ256719A patent/NZ256719A/en not_active IP Right Cessation
- 1993-10-14 IL IL10728793A patent/IL107287A/xx not_active IP Right Cessation
- 1993-10-14 DK DK93922605T patent/DK0665834T3/da active
- 1993-10-14 PT PT93922605T patent/PT665834E/pt unknown
- 1993-10-14 AU AU51545/93A patent/AU673696B2/en not_active Ceased
- 1993-10-14 DE DE69330282T patent/DE69330282T2/de not_active Expired - Fee Related
- 1993-10-14 KR KR1019950701497A patent/KR100296657B1/ko not_active IP Right Cessation
- 1993-10-14 RU RU95110937/04A patent/RU2124006C1/ru not_active IP Right Cessation
- 1993-10-14 ES ES93922605T patent/ES2160602T3/es not_active Expired - Lifetime
- 1993-10-14 WO PCT/GB1993/002125 patent/WO1994008966A1/en active IP Right Grant
- 1993-10-14 CA CA002146763A patent/CA2146763C/en not_active Expired - Fee Related
- 1993-10-15 HU HU9302933A patent/HU215386B/hu not_active IP Right Cessation
- 1993-10-18 TW TW082108623A patent/TW261616B/zh active
-
1995
- 1995-04-19 NO NO951484A patent/NO303222B1/no unknown
- 1995-04-19 FI FI951858A patent/FI110940B/fi not_active IP Right Cessation
- 1995-06-16 HU HU95P/P00226P patent/HU211741A9/hu unknown
-
1998
- 1998-12-24 HK HK98115406A patent/HK1013996A1/xx not_active IP Right Cessation
-
2001
- 2001-08-23 GR GR20010401291T patent/GR3036442T3/el not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| ES2160602T3 (es) | 2001-11-16 |
| DE69330282D1 (de) | 2001-07-05 |
| JP3315699B2 (ja) | 2002-08-19 |
| FI951858A (fi) | 1995-04-19 |
| ATE201671T1 (de) | 2001-06-15 |
| TW261616B (fi) | 1995-11-01 |
| AU5154593A (en) | 1994-05-09 |
| DE69330282T2 (de) | 2002-01-10 |
| HU215386B (hu) | 1998-12-28 |
| FI110940B (fi) | 2003-04-30 |
| GR3036442T3 (en) | 2001-11-30 |
| CA2146763A1 (en) | 1994-04-28 |
| KR100296657B1 (ko) | 2001-10-24 |
| HUT70026A (en) | 1995-09-28 |
| AU673696B2 (en) | 1996-11-21 |
| DK0665834T3 (da) | 2001-09-10 |
| HU211741A9 (en) | 1995-12-28 |
| RU2124006C1 (ru) | 1998-12-27 |
| EP0665834B1 (en) | 2001-05-30 |
| WO1994008966A1 (en) | 1994-04-28 |
| CA2146763C (en) | 2005-10-04 |
| PT665834E (pt) | 2001-11-30 |
| FI951858A0 (fi) | 1995-04-19 |
| NZ256719A (en) | 1996-11-26 |
| JPH08502282A (ja) | 1996-03-12 |
| IL107287A (en) | 2000-09-28 |
| EP0665834A1 (en) | 1995-08-09 |
| NO951484L (no) | 1995-06-19 |
| NO951484D0 (no) | 1995-04-19 |
| NO303222B1 (no) | 1998-06-15 |
| GB9319938D0 (en) | 1993-11-17 |
| IL107287A0 (en) | 1994-01-25 |
| GB9318935D0 (en) | 1993-10-27 |
| HU9302933D0 (en) | 1993-12-28 |
| RU95110937A (ru) | 1997-03-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1013996A1 (en) | Quinolone and acridinone derivatives for the treatment of urinary incontinence | |
| TW221053B (fi) | ||
| CA2258548A1 (en) | Phenylamino-substituted tricyclic derivatives for treatment of hyperproliferative diseases | |
| IL138719A0 (en) | Aminocyclohexyl ether derivatives and pharmaceutical compositions containing the same | |
| GB9322643D0 (en) | Lactam derivatives | |
| GB9305295D0 (en) | Therapeutic compounds | |
| GB9310095D0 (en) | Therapeutic compounds | |
| GB9502644D0 (en) | Heterocyclic derivatives | |
| UA42733C2 (uk) | Похідні біснафталіміду та їх фармацевтично прийнятні кислотно-адитивні солі, фармацевтична композиція з цитотоксичною активністю, яка їх містить | |
| GB9309719D0 (en) | Therapeutic agents | |
| GB9310069D0 (en) | Heterocyclic compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PF | Patent in force | ||
| PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20071014 |